SECdecoded Read filings, not jargon.

SECdecoded › VRTX

VERTEX PHARMACEUTICALS INC / MA (VRTX) recent events (8-K)

2026-07-07 1.01 Entered a material agreement
7.01 Investor-relations disclosure (Reg FD)
8.01 Other notable event
9.01 Financial statements and exhibits
SEC.gov →
2026-05-13 5.02 Executive/director departure, appointment, or pay change
5.07 Shareholder vote results
SEC.gov →
2026-05-04 2.02 Earnings release / quarterly results
9.01 Financial statements and exhibits
SEC.gov →
2026-04-29 5.02 Executive/director departure, appointment, or pay change SEC.gov →
2026-03-31 8.01 Other notable event SEC.gov →
2026-02-12 2.02 Earnings release / quarterly results
9.01 Financial statements and exhibits
SEC.gov →
2025-11-03 2.02 Earnings release / quarterly results
9.01 Financial statements and exhibits
SEC.gov →
2025-08-04 2.02 Earnings release / quarterly results
5.02 Executive/director departure, appointment, or pay change
9.01 Financial statements and exhibits
SEC.gov →
2025-05-19 8.01 Other notable event SEC.gov →
2025-05-14 5.07 Shareholder vote results SEC.gov →
2025-05-05 2.02 Earnings release / quarterly results
9.01 Financial statements and exhibits
SEC.gov →
2025-03-28 8.01 Other notable event SEC.gov →
2025-02-10 2.02 Earnings release / quarterly results
5.02 Executive/director departure, appointment, or pay change
9.01 Financial statements and exhibits
SEC.gov →
2024-12-20 7.01 Investor-relations disclosure (Reg FD) SEC.gov →
2024-11-04 2.02 Earnings release / quarterly results
9.01 Financial statements and exhibits
SEC.gov →

An 8-K is a "something material just happened" filing. Each item code above is decoded to plain English; the app explains what the event actually means for the company.

Every material event VRTX is required to disclose, decoded — earnings, executive changes, acquisitions, and more.

Open VRTX in SECdecoded → Free account · plain-English AI analysis · no card required